Novo Nordisk

FDA Adds New Warning for Ileus to Ozempic Label
FDA Adds New Warning for Ileus to Ozempic Label
HCP Live
Novo Nordisk
Ozempic
diabetes
weight losss
FDA
ileus
labeling
Flag link:
Novo Nordisk, Evotec partner in metabolic disease drug discovery pact
Novo Nordisk, Evotec partner in metabolic disease drug discovery pact
BioPharma Dive
Novo Nordisk
Evotec
drug discovery
LAB eN²
metabolic diseases
Flag link:
Novo Nordisk and Valo to research cardiometabolic treatments
Novo Nordisk and Valo to research cardiometabolic treatments
Reuters
Novo Nordisk
Valo Health
R&D
artificial intelligence
cardiometabolic diseases
Flag link:
Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
Yahoo/Bloomberg
Novo Nordisk
Ozempic
Wegovy
obesity
weight loss
Flag link:
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Fast Company
Novo Nordisk
Ozempic
logo
branding
diabetes
weight loss
Flag link:
Novo Nordisk Foundation to establish €127 million cell therapy plant
Novo Nordisk Foundation to establish €127 million cell therapy plant
Biopharma Reporter
Novo Nordisk
cell therapy
Denmark
Flag link:
Why Novo Nordisk Stock Edged Higher Today
Why Novo Nordisk Stock Edged Higher Today
Motley Fool
Novo Nordisk
Ypsomed
drug manufacturing
Flag link:
Inside the FDA's Form 483 findings at Novo Nordisk's North Carolina semaglutide plant
Inside the FDA's Form 483 findings at Novo Nordisk's North Carolina semaglutide plant
Fierce Pharma
Novo Nordisk
FDA
drug manufacturing
semaglutide
North Carolina
Flag link:
Novo Nordisk taps Aspen to help produce insulin for Africa
Novo Nordisk taps Aspen to help produce insulin for Africa
Fierce Pharma
Novo Nordisk
diabetes
Africa
insulin
Aspen Pharmacare
drug manufacturing
Flag link:
Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant
Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant
Investors Business Daily
Novo Nordisk
drug manufacturing
FDA
Wegovy
Flag link:
Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly
Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly
Reuters
Novo Nordisk
Wegovy
PCI Pharma Services
drug manufacturing
Flag link:
Ozempic-Maker Invests in Renewables
Ozempic-Maker Invests in Renewables
Daily Upside
Novo Nordisk
sustainability
renewable energy
Flag link:
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Fierce Pharma
Novo Nordisk
Eli Lilly
GLP-1 agonist
obesity
Flag link:
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
Medical News Today
Novo Nordisk
Ozempic
semaglutide
type 1 diabetes
Flag link:
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
Flag link:
Novo Nordisk Is Already Working on Ozempic 2.0
Novo Nordisk Is Already Working on Ozempic 2.0
Motley Fool
Novo Nordisk
diabetes
obesity
weight loss
Ozempic
Wegovy
Flag link:
The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company
Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company
FT.com
Novo Nordisk
Wegovy
Europe
weight loss
Flag link:
Novo Nordisk launches Wegovy for obese patients in UK
Novo Nordisk launches Wegovy for obese patients in UK
Pharmaceutical Business Review
Novo Nordisk
UK
Wegovy
obesity
Flag link:
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Clinical Trials Arena
Novo Nordisk
Wegovy
Ozempic
Denmark
Flag link:

Pages